Discovering and Overcoming Roadblocks in Crossing the Blood-Brain Barrier

Bispecific TfR/BACE1 antibodies have shown promise for boosting antibody uptake in brain. The blood-brain barrier (BBB) continues to hinder the development of therapies for neurological…

Understanding Lung Cancer

Get the facts and know your risk…

Systemic and Polyarticular Juvenile Arthritis

Learn the common symptoms, diagnosis, and treatment options for polyarticular juvenile idiopathic arthritis (PJIA) and systemic juvenile idiopathic arthritis (SJIA). PJIA and SJIA are types…

Calling All Citizen Scientists

We recently received an intriguing plea for help from one Ralph Swoyer, an artisinal cheese maker known for his local cheese, Ralph's Killer Muenster. Ralph reached out to us because of our…

Partners for Good: Eastside Prep

Eastside Prep offers East Palo Alto students the opportunity to develop the skills, knowledge, and confidence to pursue a college education. With Genentech's support, the school has grown…

A Place for New Perspectives

Take an aerial tour of Genentech's South San Francisco campus, a place made special by geography, history, and the people who work here everyday…

College Ambassadors

Genentech's College Ambassadors are former interns who help fellow students learn about internship opportunities and what it's like to work at the company…

Better Chemistry

Learn about Genentech's grassroots Green BioPharma program, which aims to reduce the environmental impact of our research and development…

What is HER2-Positive Metastatic Breast Cancer?

Learn about metastatic, or advanced, breast cancer, which may also be HER2-positive…

Understanding Antibody-Drug Conjugates

ADCs combine three components to provide a unique treatment option…

We ♥ Science

At Genentech we're in love with science. And we believe there's a scientist in all of us…

How to Get Into the Brain

Ryan Watts and Mark Dennis explain how they found a new way to get medicines through the blood-brain barrier, and how Genentech supports groundbreaking science…

Understanding Colorectal Cancer

Get the facts and know your risk…

Our Research Vision

Rigorous and groundbreaking science has always been at the core of what we do at Genentech. Our unique emphasis on strong basic research combined with an applied focus on translational…

Journeys: Michelle Aguayo

Michelle Aguayo shares how caring for patients led to her work at Genentech Access Solutions, where she helps patients get the medicines they need, regardless of their ability to pay…

Genentech, Inside and Out

Mark Helton, a US Air Force veteran, discusses life inside and outside Genentech, and how working here gives him a sense of purpose…

Genentech Access Solutions works for patients

Genentech Access Solutions patients get the help they need to manage the challenges that come with care. These are some of their stories…

20 Years of Celebrating Our Community

Genentech Employees Support Local Businesses Two thousand and twelve marks the 20th Anniversary of the Genentech Goes to Town program in South San Francisco. The program supports…

Celebrating Patients for mBC Awareness

In 2010, we partnered with Living Beyond Breast Cancer, Metastatic Breast Cancer Network, and MetaVivor to recognize people living in the US with metastatic breast cancer (MBC), a disease…

Visualizing gRide's Impact

gRide, our employee commuting program, has passed a major milestone! We've saved 100 million miles of commuting since the program's inception in late 2006…

Genentech Gives Back 2012

We're passionate about giving back to the  the communities in which we live and work. Genentech Gives Back encourages employees to support local and global non-profits in a variety of ways…

Understanding Rheumatoid Arthritis

RA occurs when the immune system inappropriately attacks joint tissue. Get the facts and know the warning signs…

Journeys: Bob Cohen

Genentech scientist Bob Cohen chose to shift from practicing oncology to researching new treatment options for cancer patients. This is science in the pursuit of patient care…

100 Million Miles Saved and Counting

gRide, Genentech's employee commuting program, encourages the use of cleaner transportion, such as buses, bicycles, carpools and vanpools. In the summer of 2012, the program surpassed a…

Alzheimer's Prevention Trial - About Genentech's Involvement

Genentech, the Banner Alzheimer's Institute, and the National Institutes of Health are collaborating on the first-ever prevention trial in cognitively healthy individuals who are likely to…

Alzheimer's Prevention Trial - A Unique Patient Population

Genentech, the Banner Alzheimer's Institute, and the National Institutes of Health are collaborating on the first-ever prevention trial in cognitively healthy individuals who are likely to…

Alzheimer's Prevention Trial - Science and Significance

Genentech, the Banner Alzheimer's Institute, and the National Institutes of Health are collaborating on the first-ever prevention trial in cognitively healthy individuals who are likely to…

Gene Expressions: Understanding Biomarkers

Genentech scientist Jeff Settleman explains biomarkers and their potential for identifying which patients may benefit from certain treatments…

Science is Personal: Patients

Learn more about Genentech's work with patients and advocacy groups, including the Gastric Cancer Fund, AIM at Melanoma, and the Tug McGraw Foundation at gene.com…

Science is Personal: Science

Breakthrough science is what we do…

Science is Personal: People

People make Genentech what it is…

Patient Perspectives: Paul & Roger

Paul, a stroke patient, and Roger, a heart attack patient, offer their perspective on what it's like to experience a sudden health event, and the importance of getting to the hospital…

Patient Perspectives: Brenda & Elaine

Rheumatoid Arthritis patients Brenda and Elaine discuss the impact of their diagnosis, and how dealing with a chronic disease affects their daily lives…

Patient Perspectives: Martin & Stacy

Martin and Stacy discuss how receiving an organ transplant changed their lives…

Partners for Good: Dream Foundation

Genentech helps the Dream Foundation make dreams come true for adults facing life-threatening illness…

Partners for Good: First Descents

First Descents offers free outdoor adventures -- kayaking, surfing, climbing -- to young adults dealing with cancer. In August 2012, Genentech employees and cancer fighters joined First…

Gene Expressions: The RAS-RAF Pathway: New Cancer Research

Chris Bowden, VP of Product Development at Genentech provides a close-up look at the RAS-RAF pathway, an important and evolving area of cancer research…

Gene Expressions: The Hedgehog Signaling Pathway and Cancer

Frederic de Sauvage, VP of Molecular Biology, explains Genentech's role towards understanding the relationship between the Hedgehog signaling pathway and cancer…

Gene Expressions: The HER Pathway and Cancer

Genentech VP of Clinical Oncology Dietmar Berger discusses the role of the HER2 receptor in metastatic breast cancer…

Gene Expressions: The Met Signaling Pathway and Cancer

Genentech scientist Bob Yauch explains the role of the Met signaling pathway in cancer, and how investigational medicines are targeting the pathway…